Accelus Stock
Accelus is an minimally invasive spine surgery through its procedure-enabling technology.
Sign up today and learn more about Accelus Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Accelus Stock
Accelus is committed to accelerating minimally invasive spine surgery through its procedure-enabling technology with broad accessibility to previously underserved markets.
Management
Chief Executive Officer & Co-Founder
Christopher Walsh
Chief Strategy Officer (CSO)
Andrew Wolf
Director of Clinical Research
Rachelle Yusufbekov
Chief Robotics Officer
Kevin T. Foley
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
